[HTML][HTML] Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
Y Lin, R Lin, HB Lin, S Shen - Medicine in Drug Discovery, 2024 - Elsevier
Atherosclerosis, a highly prevalent cardiovascular disease, has significantly contributed to
morbidity and mortality worldwide. Despite the availability of various treatment options in …
morbidity and mortality worldwide. Despite the availability of various treatment options in …
Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy
Y Li, Q Feng, L Wang, X Gao, Y Xi, L Ye, J Ji… - Journal of Drug …, 2024 - Taylor & Francis
Atherosclerosis is one of the major causes of death worldwide, and it is closely related to
many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although …
many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although …
Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
Z Xiao, Y Li, L Xiong, J Liao, Y Gao, Y Luo… - Advanced …, 2023 - Wiley Online Library
Atherosclerosis, the leading cause of death worldwide, is responsible for≈ 17.6 million
deaths globally each year. Most therapeutic drugs for atherosclerosis have low delivery …
deaths globally each year. Most therapeutic drugs for atherosclerosis have low delivery …
[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …
Recent advances in inhibiting atherosclerosis and restenosis: From pathogenic factors, therapeutic molecules to nano-delivery strategies
X Wang, B Gao, Y Feng - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
Due to dominant atherosclerosis etiology, cardiovascular diseases (CVDs) remain the
leading cause of morbidity and mortality worldwide. In clinical trials, advanced …
leading cause of morbidity and mortality worldwide. In clinical trials, advanced …
Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy
Y Li, J Wang, J Xie - Smart Medicine, 2023 - Wiley Online Library
Atherosclerosis is a typical chronic inflammatory vascular disease that seriously endangers
human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used …
human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used …
Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis
L Ou, S Zhong, J Ou, J Tian - Acta Pharmacologica Sinica, 2021 - nature.com
Atherosclerosis (AS) is the main pathological cause of coronary heart disease (CHD).
Current clinical interventions including statin drugs can effectively reduce acute myocardial …
Current clinical interventions including statin drugs can effectively reduce acute myocardial …
Atherosclerosis Treatment with Stimuli‐Responsive Nanoagents: Recent Advances and Future Perspectives
A Maruf, Y Wang, T Yin, J Huang… - Advanced …, 2019 - Wiley Online Library
Atherosclerosis is the root of approximately one‐third of global mortalities. Nanotechnology
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …
Nanotechnology for targeted therapy of atherosclerosis
S Hossaini Nasr, X Huang - Frontiers in Pharmacology, 2021 - frontiersin.org
Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of
death in the world. Nanomedicine is a powerful tool that can be engineered to target …
death in the world. Nanomedicine is a powerful tool that can be engineered to target …
Nanomedicine-based strategies for treatment of atherosclerosis
M Schiener, M Hossann, JR Viola… - Trends in molecular …, 2014 - cell.com
Atherosclerosis is a chronic inflammatory disease of the arterial wall that arises from an
imbalanced lipid metabolism and a maladaptive inflammatory response. Despite intensive …
imbalanced lipid metabolism and a maladaptive inflammatory response. Despite intensive …